192 related articles for article (PubMed ID: 10589398)
1. Cranial suture obliteration is induced by removal of transforming growth factor (TGF)-beta 3 activity and prevented by removal of TGF-beta 2 activity from fetal rat calvaria in vitro.
Opperman LA; Chhabra A; Cho RW; Ogle RC
J Craniofac Genet Dev Biol; 1999; 19(3):164-73. PubMed ID: 10589398
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta 2 and TGF-beta 3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis.
Opperman LA; Adab K; Gakunga PT
Dev Dyn; 2000 Oct; 219(2):237-47. PubMed ID: 11002343
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro.
Opperman LA; Nolen AA; Ogle RC
J Bone Miner Res; 1997 Mar; 12(3):301-10. PubMed ID: 9076572
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta 3(Tgf-beta3) in a collagen gel delays fusion of the rat posterior interfrontal suture in vivo.
Opperman LA; Moursi AM; Sayne JR; Wintergerst AM
Anat Rec; 2002 Jun; 267(2):120-30. PubMed ID: 11997880
[TBL] [Abstract][Full Text] [Related]
5. Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro.
Opperman LA; Passarelli RW; Morgan EP; Reintjes M; Ogle RC
J Bone Miner Res; 1995 Dec; 10(12):1978-87. PubMed ID: 8619379
[TBL] [Abstract][Full Text] [Related]
6. Timing of Egf treatment differentially affects Tgf-beta2 induced cranial suture closure.
Rawlins JT; Fernandez CR; Cozby ME; Opperman LA
Exp Biol Med (Maywood); 2008 Dec; 233(12):1518-26. PubMed ID: 18849541
[TBL] [Abstract][Full Text] [Related]
7. Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures.
Opperman LA; Sweeney TM; Redmon J; Persing JA; Ogle RC
Dev Dyn; 1993 Dec; 198(4):312-22. PubMed ID: 8130378
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cranial suture morphogenesis.
Ogle RC; Tholpady SS; McGlynn KA; Ogle RA
Cells Tissues Organs; 2004; 176(1-3):54-66. PubMed ID: 14745235
[TBL] [Abstract][Full Text] [Related]
9. Regional differentiation of cranial suture-associated dura mater in vivo and in vitro: implications for suture fusion and patency.
Greenwald JA; Mehrara BJ; Spector JA; Warren SM; Crisera FE; Fagenholz PJ; Bouletreau PJ; Longaker MT
J Bone Miner Res; 2000 Dec; 15(12):2413-30. PubMed ID: 11127206
[TBL] [Abstract][Full Text] [Related]
10. Studies in cranial suture biology: Part I. Increased immunoreactivity for TGF-beta isoforms (beta 1, beta 2, and beta 3) during rat cranial suture fusion.
Roth DA; Longaker MT; McCarthy JG; Rosen DM; McMullen HF; Levine JP; Sung J; Gold LI
J Bone Miner Res; 1997 Mar; 12(3):311-21. PubMed ID: 9076573
[TBL] [Abstract][Full Text] [Related]
11. Dura mater maintains rat cranial sutures in vitro by regulating suture cell proliferation and collagen production.
Opperman LA; Chhabra A; Nolen AA; Bao Y; Ogle RC
J Craniofac Genet Dev Biol; 1998; 18(3):150-8. PubMed ID: 9785219
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta3 (Tgf-beta3) down-regulates Tgf-beta3 receptor type I (Tbetar-I) during rescue of cranial sutures from osseous obliteration.
Opperman LA; Galanis V; Williams AR; Adab K
Orthod Craniofac Res; 2002 Feb; 5(1):5-16. PubMed ID: 12071374
[TBL] [Abstract][Full Text] [Related]
13. Nasal capsular cartilage is required for rat transpalatal suture morphogenesis.
Adab K; Sayne JR; Carlson DS; Opperman LA
Differentiation; 2003 Oct; 71(8):496-505. PubMed ID: 14641330
[TBL] [Abstract][Full Text] [Related]
14. Craniosynostosis and altered patterns of fetal TGF-beta expression induced by intrauterine constraint.
Kirschner RE; Gannon FH; Xu J; Wang J; Karmacharya J; Bartlett SP; Whitaker LA
Plast Reconstr Surg; 2002 Jun; 109(7):2338-46; discussion 2347-54. PubMed ID: 12045561
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta2 stimulates cranial suture closure through activation of the Erk-MAPK pathway.
Lee SW; Choi KY; Cho JY; Jung SH; Song KB; Park EK; Choi JY; Shin HI; Kim SY; Woo KM; Baek JH; Nam SH; Kim YJ; Kim HJ; Ryoo HM
J Cell Biochem; 2006 Jul; 98(4):981-91. PubMed ID: 16795080
[TBL] [Abstract][Full Text] [Related]
16. Studies in cranial suture biology: up-regulation of transforming growth factor-beta1 and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture fusion in the rat.
Most D; Levine JP; Chang J; Sung J; McCarthy JG; Schendel SA; Longaker MT
Plast Reconstr Surg; 1998 May; 101(6):1431-40. PubMed ID: 9583470
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated transmission of a dominant negative transforming growth factor-beta receptor inhibits in vitro mouse cranial suture fusion.
Mehrara BJ; Spector JA; Greenwald JA; Ueno H; Longaker MT
Plast Reconstr Surg; 2002 Aug; 110(2):506-14. PubMed ID: 12142669
[TBL] [Abstract][Full Text] [Related]
18. Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects.
Ito Y; Yeo JY; Chytil A; Han J; Bringas P; Nakajima A; Shuler CF; Moses HL; Chai Y
Development; 2003 Nov; 130(21):5269-80. PubMed ID: 12975342
[TBL] [Abstract][Full Text] [Related]
19. Cranial sutures as intramembranous bone growth sites.
Opperman LA
Dev Dyn; 2000 Dec; 219(4):472-85. PubMed ID: 11084647
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta1, FGF-2, and receptor mRNA expression in suture mesenchyme and dura versus underlying brain in fusing and nonfusing mouse cranial sutures.
Gosain AK; Recinos RF; Agresti M; Khanna AK
Plast Reconstr Surg; 2004 May; 113(6):1675-84. PubMed ID: 15114129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
